We are live on ! Find out more
Citadel Advisors

Citadel Advisors Portfolio holdings

AUM $618B
1-Year Est. Return 30.34%
 

Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.

This Fund
S&P 500
This Quarter Est. Return
+22.33%
1 Year Est. Return
+30.34%
3 Year Est. Return
+94.87%
5 Year Est. Return
+105.94%
10 Year Est. Return
+433.28%
AUM
$385B
AUM Growth
+$32.1B
Cap. Flow
-$35.1B
Cap. Flow %
-9.14%
Top 10 Hldgs %
30.5%
Holding
11,975
New
1,989
Increased
4,461
Reduced
4,218
Closed
1,130

Sector Composition

Rank Sector Weight
1 Technology 3.66%
2 Healthcare 3.16%
3 Industrials 2.01%
4 Financials 1.98%
5 Consumer Discretionary 1.96%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CBIO
9851
PUT
Crescent Biopharma
CBIO
$600M
$142K ﹤0.01%
377
+276
+273% +$96.7K
LXRX icon
9852
PUT
Lexicon Pharmaceuticals
LXRX
$1.09B
$142K ﹤0.01%
41,600
+24,800
+148% +$47.3K
SLS icon
9853
CALL
SELLAS Life Sciences
SLS
$2.34B
$142K ﹤0.01%
+24,400
New +$97.7K
CCEC
9854
CALL
Capital Clean Energy Carriers
CCEC
$1.37B
$142K ﹤0.01%
17,500
-23,200
-57% -$176K
CVA
9855
PUT
DELISTED
Covanta Holding Corporation
CVA
$142K ﹤0.01%
10,800
-700
-6% -$7.57K
GLRE icon
9856
Greenlight Captial
GLRE
$504M
$141K ﹤0.01%
19,303
-25,400
-57% -$188K
SIGA icon
9857
SIGA Technologies
SIGA
$224M
$141K ﹤0.01%
19,380
-114,017
-85% -$804K
WVE icon
9858
PUT
Wave Life Sciences
WVE
$1.16B
$141K ﹤0.01%
17,900
-25,500
-59% -$214K
AVCT
9859
DELISTED
American Virtual Cloud Technologies, Inc. Common Stock
AVCT
$141K ﹤0.01%
+1,308
New +$94.1K
GTES icon
9860
CALL
Gates Industrial Corporation Ltd.
GTES
$7.49B
$140K ﹤0.01%
+11,000
New +$138K
ACRE
9861
PUT
Ares Commercial Real Estate
ACRE
$252M
$139K ﹤0.01%
+11,700
New +$125K
ATXS
9862
DELISTED
Astria Therapeutics
ATXS
$139K ﹤0.01%
+10,847
New +$193K
OSW icon
9863
PUT
OneSpaWorld
OSW
$2.7B
$139K ﹤0.01%
13,700
+1,800
+15% +$14.2K
MTRX icon
9864
CALL
Matrix Service
MTRX
$334M
$138K ﹤0.01%
+12,500
New +$115K
AIXC
9865
AIxCrypto Holdings Inc
AIXC
$16.1M
$138K ﹤0.01%
92
-15
-14% -$29.3K
BREZ
9866
DELISTED
Breeze Holdings Acquisition Corp. Common Stock
BREZ
$138K ﹤0.01%
+13,553
New +$138K
CENX icon
9867
Century Aluminum
CENX
$4.65B
$137K ﹤0.01%
+12,406
New +$113K
ISBC
9868
PUT
DELISTED
Investors Bancorp, Inc.
ISBC
$137K ﹤0.01%
+13,000
New +$119K
RPAI
9869
PUT
DELISTED
RETAIL PROPERTIES OF AMERICA, INC.
RPAI
$137K ﹤0.01%
+16,000
New +$117K
CFRX
9870
DELISTED
ContraFect Corporation
CFRX
$137K ﹤0.01%
338
+186
+122% +$80.5K
ASMB icon
9871
CALL
Assembly Biosciences
ASMB
$530M
$136K ﹤0.01%
1,867
-450
-19% -$52.8K
CRBP icon
9872
Corbus Pharmaceuticals
CRBP
$178M
$136K ﹤0.01%
+3,637
New +$136K
TXMD icon
9873
PUT
TherapeuticsMD
TXMD
$23.8M
$136K ﹤0.01%
2,240
-152
-6% -$10.4K
GHSI
9874
DELISTED
Guardion Health Sciences, Inc. Common Stock
GHSI
$136K ﹤0.01%
1,095
-46
-4% -$3.21K
ACCO icon
9875
CALL
Acco Brands
ACCO
$400M
$135K ﹤0.01%
16,000
-400
-2% -$2.9K

Similar funds

Citadel Advisors's Q4 2020 Portfolio in Review

As of Q4 2020, Citadel Advisors held 11,975 positions worth $385B, up 9.1% from $353B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Citadel Advisors withdrew a net $35.1B in Q4 2020, closing 1,130 positions and reducing 4,218 holdings. Its most notable exit was Immunomedics Inc, an estimated $213M position sold in full.

By sector, the portfolio is most concentrated in Technology at 3.7% of assets, up from 3% a quarter earlier, followed by Healthcare and Industrials.

Against the trend, Citadel Advisors opened a new position in S&P Global worth $114M.

  • Citadel Advisors's largest Q4 2020 buy was S&P Global: 345,785 shares worth $114M.
  • Citadel Advisors added most to iShares Core S&P 500 ETF in Q4 2020, an estimated $1.16B increase.
  • Citadel Advisors's biggest Q4 2020 reduction was Amazon, cutting an estimated $1.55B.
  • Citadel Advisors fully exited Immunomedics Inc in Q4 2020, selling an estimated $213M.
  • Citadel Advisors's ten largest holdings make up 31% of its $385B portfolio in Q4 2020.
  • Citadel Advisors opened 1,989 new positions and closed 1,130 in Q4 2020.
  • Citadel Advisors's portfolio value rose 9.1% quarter-over-quarter to $385B.

Based on Citadel Advisors's 13F filing for Q4 2020, filed 16 Feb 2021.